Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
NIH head says public distrust prompted mRNA vaccine rollback
The explanation differs from that given by RFK Jr. and comes amid calls for leadership to provide accurate information about vaccines to the public.
Gabrielle Masson
Aug 12, 2025 2:08pm
Biohaven trashes troriluzole in OCD after ph. 3 fail
Aug 12, 2025 2:06pm
ARPA-H data chief departs over mRNA vax cancellations
Aug 12, 2025 12:15pm
Bayer picks Kumquat for $1.3B KRAS collaboration
Aug 12, 2025 6:29am
Novartis scores 3rd phase 3 win for ianalumab this week
Aug 12, 2025 5:09am
PureTech creates Celea to develop promising lung disease drug
Aug 12, 2025 10:46am
More News
Trinity Biotech says its 15-day CGM works without fingersticks
Aug 12, 2025 12:30pm
Avantor under pressure from activist investor Engine Capital
Aug 12, 2025 11:30am
Vaxart seeks answers as BARDA vaccine funding dries up again
Aug 12, 2025 5:08am
Fierce Biotech Layoff Tracker 2025: Poseida, Absci & more
Aug 11, 2025 2:50pm